Exploring how to implement injectable buprenorphine for treating opioid use disorder in clinics
Examining injectable buprenorphine implementation strategies in low-threshold and primary care settings
This study is looking at how to make it easier for doctors and clinics to offer a helpful injection treatment for people struggling with opioid use disorder, so that more patients can get the care they need.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Albert Einstein College of Medicine NIH-funded |
| Lab location | 1 site (Bronx, United States) |
| Project ID | NIH-10873766 on NIH RePORTER |
What this research studies
This research focuses on improving the implementation of injectable buprenorphine, a treatment for opioid use disorder (OUD), in both primary care and low-threshold clinic settings. The project aims to identify barriers to the use of this treatment and develop strategies to enhance its adoption. Over a 30-month period, the research will involve assessing the effectiveness of these strategies and examining any gaps in care that arise after implementation. Patients may benefit from a more accessible and effective treatment option for OUD.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with opioid use disorder who may benefit from injectable treatment options.
Not a fit: Patients who do not have opioid use disorder or those who are not interested in injectable treatment options may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved access to injectable buprenorphine, enhancing treatment outcomes for individuals with opioid use disorder.
How similar studies have performed: Previous research has shown promising results with injectable buprenorphine in clinical trials, indicating potential for success in real-world implementation.
Where this research is happening
Bronx, United States
- Albert Einstein College of Medicine — Bronx, United States (Active)
Researchers
- Principal investigator: Jakubowski, Andrea U — Albert Einstein College of Medicine
- Study coordinator: Jakubowski, Andrea U
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.